Details of the spectacular workings of the WILBUR LEO watch movement
NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) — Wilbur Watch Co. is proud to announce that it has been voted the 2024 American Watch Brand of the Year at the prestigious WatchPro Awards in New York City. This esteemed award recognizes the innovative craftsmanship, forward-thinking design, and unparalleled commitment to excellence that Wilbur Watch Co. has embodied since its inception.
The WatchPro Awards, one of the most respected accolades in the watchmaking industry, are determined by votes from leading industry professionals, including retailers, brands, and insiders. In a highly competitive year, Wilbur Watch Co. stood out for its bold designs and precision engineering, pushing the boundaries of modern horology.
“We’re not here to follow the rules; we’re here to break them. This award is a testament to disrupting the ordinary and creating something daring, unapologetic, and unforgettable,” said Jason Wilbur, Founder and CEO of Wilbur Watch Co. “This is just the beginning. We’re redefining what it means to wear a watch, and we’re grateful to everyone who believes in our mission to push beyond the expected.”
The ceremony, held on the evening of September 4th, 2024, celebrated the finest in the watch industry, and Wilbur Watch Co.’s win underscores its commitment to reshaping the landscape of luxury timepieces.
For more information about Wilbur Watch Co. and its award-winning collections, visit WilburCo.com.
About Wilbur Watch Co.
Wilbur Watch Co. is an American-based watch brand known for its avant-garde designs, precise engineering, and dedication to innovation. With each timepiece, Wilbur challenges the conventions of traditional watchmaking to deliver a bold, unapologetic statement in horology.
Watch Pro Awards – American Watch Brand of the Year
Wilbur Watch Co. voted American Watch Brand of the Year
Photos accompanying this announcement are available at:
AI-Media and Speechmatics today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.
BROOKLYN, N.Y., Sept. 13, 2024 (GLOBE NEWSWIRE) — AI-Media – the global leader in audiovisual encoding technology and AI-driven transcription and translation solutions, and Speechmatics – the market leader in speech recognition technology, today announce a strategic expansion of their multi-year partnership to deliver new and better AI-driven products to market.
This partnership brings together Speechmatics’ leading speech-to-text technology and AI-Media’s unique iCap-based encoding appliances and secure network that seamlessly embeds the technology within customers’ existing workflows and automation systems.
By integrating these capabilities, AI-Media’s LEXI 3.0 has been the first AI product to overtake the quality of human-in-the-loop alternatives in the live video market – at a fraction of the cost.
Tony Abrahams, CEO of AI-Media, shared his thoughts on the partnership:
“Our data derived from the performance of LEXI 3.0 has shown Speechmatics to be one of our most trusted engines over the last two years, consistently delivering accurate results that continue to improve. This partnership brings our two companies even closer as we co-develop and ideate innovative solutions for the future of captioning and translation.
Together, we will create solutions that are accurate, reliable and adaptable to the diverse needs of our global clientele.
This collaboration deepens the partnership that has seen AI-Media’s iCap encoding ecosystem emerge as the leading choice of broadcasters and government customers around the world looking to get the best possible performance from these game changing AI technologies from Speechmatics.”
By leveraging Speechmatics’ advanced speech recognition engine and AI-Media’s cutting-edge workflow and encoding technologies, this partnership addresses the diverse and complex needs of various industries, from broadcasting to government and enterprise sectors.
The partnership broadens Speechmatics’ reach by integrating its core technology into AI-Media’s LEXI 3.0 product.
Extending the success of LEXI 3.0 into the European broadcast market is a near term objective – Speechmatics’ emerging multilingual capabilities align perfectly with AI-Media’s growth plans.
A Vision for the Future
This new partnership elevates AI-Media to become Speechmatics’ largest live captioning market partner, marking a significant milestone in their collaboration.
“Speechmatics has become the leading Automatic Speech Recognition (ASR) provider within broadcast because of our high accuracy and low latency across multiple languages, both live and offline. AI-Media has successfully integrated our technology into their market leading broadcast infrastructure to achieve impressive growth in their chosen markets, and this strategic partnership brings closer collaboration to allow for more rapid innovation and agility. As a result, global broadcasters will continue to get the best captioning service on the market and our combined strength in AI driven captioning can be utilised in a broader array of verticals,” said Katy Wigdahl, CEO of Speechmatics.
Together, AI-Media and Speechmatics are committed to integrating best-in-class technologies to set new industry standards. This collaboration is not just a technical integration but a partnership of vision and innovation, aimed at continuously evolving and adapting to the dynamic demands of the global language services market.
Visit AI-Media at IBC 2024
Experience AI-Media’s latest innovations at IBC 2024 and discover why broadcasters and organisations worldwide trust AI-Media and LEXI to transform their captioning workflows. To book a 1:1 meeting click HERE. For more information, visit ai-media.tv.
About AI-Media
Founded in Australia in 2003, AI-Media is a pioneering technology company specialising in AI language and captioning workflow solutions.
As a global leader, AI-Media provides high-quality AI-powered live and recorded captioning and translation technology and solutions to a diverse range of customers and markets worldwide.
For the first time in February 2024, AI-Media unveiled groundbreaking data showcasing the superiority of its AI captioning product, LEXI, over traditional more expensive human workflows in the live video market.
With deep industry experience and sophisticated AI technology to create solutions which streamline and simplify processes, AI-Media empowers leading broadcasters, enterprises and government agencies globally to ensure seamless accessibility and inclusivity of their content.
AI-Media (ASX: AIM) commenced trading on the ASX on 15 September 2020.
Visit Speechmatics at IBC 2024
Join Speechmatics at IBC 2024 and explore the latest advancements in Automatic Speech Recognition (ASR) technology. Discover why leading broadcasters and organizations like AI Media trust Speechmatics for real-time, accurate, and scalable ASR solutions. To schedule a 1:1 meeting, click HERE. For more information, visit speechmatics.com
About Speechmatics
Speechmatics is a global leader in Automatic Speech Recognition (ASR) technology, trusted by the biggest brands in the media and broadcasting industry. Our cutting-edge ASR solutions deliver the lowest latency and highest accuracy in the market, providing broadcasters with the fastest, most reliable real-time transcription services available.
Pioneering Innovation in ASR: We continuously push the boundaries of ASR technology to ensure our customers stay ahead. Our solutions not only capture spoken words but also recognize audio events such as laughter, applause, and music, setting us apart from the competition.
We’re excited to introduce Ursa 2, our latest breakthrough mode, offering an 18% reduction in errors across 50 languages, including enhanced support for Arabic dialects, Irish, and Maltese—bringing our language coverage to all 24 official EU languages. With latency reduced to under 1 second, Ursa 2 enhances real-time transcription at lightning-fast speed without compromising accuracy.
For broadcasters and organizations aiming for precision and speed in their captioning workflows, Speechmatics is the go-to choice.
Media Contact: Fiona Habben – Fiona.habben@ai-media.tv
WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced the pricing of its upsized initial public offering of 13,235,294 shares of its common stock at an initial public offering price of $17.00 per share. All of the shares are being offered by Zenas. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $225.0 million. Zenas’ common stock is expected to begin trading on the Nasdaq Global Select Market on September 13, 2024 under the ticker symbol “ZBIO”. The offering is expected to close on September 16, 2024, subject to the satisfaction of customary closing conditions. In addition, Zenas has granted the underwriters a 30-day option to purchase up to an additional 1,985,294 shares of common stock at the initial public offering price, less underwriting discounts and commissions.
Morgan Stanley, Jefferies, Citigroup, and Guggenheim Securities are acting as joint book-running managers for the offering.
Registration statements relating to the shares being sold in the offering have been filed with the U.S. Securities and Exchange Commission (“SEC”) and became effective on September 12, 2024. The offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, or by email at prospectus@morganstanley.com; and from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, NY 10022, by telephone at (877) 821-7388, or by email at Prospectus_Department@Jefferies.com.
This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.
About Zenas BioPharma, Inc.
Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative immunology-based therapies for patients in need. Our core business strategy combines our experienced leadership team with a disciplined product candidate acquisition approach to identify, acquire and develop product candidates globally that we believe can provide superior clinical benefits to patients living with autoimmune diseases. Zenas’ lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.
Forward-Looking Statements
This press release contains forward-looking statements. Investors are cautioned not to place undue reliance on these forward-looking statements, including statements about the completion, timing and size of the initial public offering and the commencement of trading on the Nasdaq Global Select Market. Each forward-looking statement is subject to the inherent uncertainties in predicting future results and conditions and no assurance can be given that the initial public offering discussed above will be completed on the terms described or at all. Completion of the proposed initial public offering and the terms thereof are subject to numerous factors, many of which are beyond the control of Zenas, including, without limitation, market conditions, failure of customary closing conditions and the factors discussed in the “Risk Factors” section of the prospectus that forms a part of the registration statement, in the form last filed with the SEC. These forward-looking statements speak only as of the date of this press release and Zenas undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Contact: Matthew Osborne
Investor Relations and Corporate Communications Matt.osborne@zenasbio.com
The King Salman Humanitarian Aid and Relief Center (KSrelief) has been a beacon of hope for mine victims in Yemen. Through its Prosthetic Limbs and Rehabilitation Center in Aden, KSrelief has provided essential services to thousands of individuals affected by the devastating conflict.
In the sixth phase of the project, from September 2023 to June 2024, the center provided prosthetic limbs, orthotic devices, and physiotherapy to 2,961 patients. This included the installation of 413 new prosthetic limbs and the maintenance of 450 existing ones.
KSrelief's efforts extend beyond providing medical care. The center has worked to localize and improve rehabilitation services, empowering local staff and ensuring the highest quality of care.
In addition to its rehabilitation efforts, KSrelief's Masam Project, dedicated to clearing mines in Yemen, has helped clear 458,477 mines from Yemeni lands, significantly reducing the risk of injuries.
These initiatives reflect Saudi Arabia's unwavering commitment to human
itarian aid and its dedication to supporting those affected by conflict.
Source: Saudi Press Agency
The General Authority for the Care of the Affairs of the Prophet's Mosque provided integrated services to the Prophet's Mosque, which attracted 5,410,089 worshippers and visitors last week.
In accordance with the organisational procedures for organising crowds and visiting dates, the authority reported in a statistical report on the total services provided to worshippers and visitors at the Prophet's Mosque that 477,245 visitors greeted the Prophet and his two companions and 230,823 visitors performed prayers at the blessed Rawdah.
The authority reported that communication services in multiple languages were utilised by 77,054 visitors from a variety of nationalities.
In addition to the provision of 1,570 tonnes of Zamzam water, the field services included sterilisation and disinfection works, totalling 24,176 litres. It was further stated that 178 samples were collected for analysis and examination. One hundred forty-four thousand three hundred fifty-two fasting iftar meals were distributed in the des
ignated areas of the Prophet's Mosque for fasting people's iftar.
Source: Saudi Press Agency
The General Directorate of Civil Defense has issued a warning about ongoing thunderstorms in several regions of Saudi Arabia, expected to last until Tuesday.
Heavy rains, hail, and strong winds are anticipated in Makkah, Taif, Maysan, Adham, and Al-Ardiyat. Moderate to heavy rains are forecast for Al-Baha, Aseer, Jazan, and Najran, while light to moderate rains are expected in Madinah.
Citizens and residents are urged to exercise caution, avoid low-lying areas, and stay updated on weather alerts.
Source: Saudi Press Agency
GlobeNewswire Distribution ID 9229707